Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:34 PM ET 10-Q
Financial Results InfuSystem Holdings, Inc INFU

InfuSystem Holdings Q3 2026 Results: Net Income $3.16M, Up 39.7% YoY

InfuSystem Holdings, Inc. reported net revenues of $37.6 million for the third quarter of 2026, a 3% increase year-over-year, with net income rising to $3.2 million compared to $2.3 million in the prior year period. The company demonstrated improved operational efficiency with operating income growing 24.5% to $4.7 million, supported by a reduction in cost of revenues and strong gross profit margins.

Key figure
Net income $3.16M · +39.7% YoY
4:33 PM ET 10-Q
Financial Results Xenon Pharmaceuticals Inc. XENE

Xenon Pharmaceuticals Q3 2026 Results: Net Loss of $110M, Loss Widens

Xenon Pharmaceuticals reported a net loss of $323.5 million for the nine months ended September 30, 2026, compared to $240.6 million in the prior year, driven by increased R&D spending on its lead candidate azetukalner. The company significantly strengthened its balance sheet, ending the period with $1.15 billion in cash, cash equivalents, and marketable securities following substantial common share issuances.

Key figure
Net loss $110M
4:33 PM ET 10-Q
Financial Results Office Properties Income Trust OPI

Office Properties Income Trust Q3 2026 Results: Net Loss of $48.9M

Office Properties Income Trust reported a net loss of $45.8 million for the third quarter of 2026, following its emergence from Chapter 11 bankruptcy on June 18, 2026. The company's financial statements are now presented using 'Successor' and 'Predecessor' accounting, reflecting a significant restructuring of its balance sheet and debt obligations.

Key figure
Net loss $48.9M
4:33 PM ET Form 4
Insider Selling Doximity, Inc. DOCS

Doximity Insider Timothy S. Cabral Sells $375K of Stock

Timothy S. Cabral sold 10,721 shares of Doximity, Inc. at $35.00 a share, worth $375K in total on Nov 5, 2026. Shares held after the trade: 8,084 (-57.0%).

Value
$375K
Shares
10,721
Price
$35.00
Holding change
-57.0%
Trade date
Nov 5, 2026
4:33 PM ET 10-Q
Financial Results Praxis Precision Medicines, Inc. PRAX

Praxis Precision Medicines Q3 2026 Results: Net Loss of $94.2M, Loss Widens

Praxis Precision Medicines reported a net loss of $94.2 million for the third quarter of 2026, compared to $73.9 million in the prior year period, driven by increased general and administrative expenses. The company significantly strengthened its balance sheet through a follow-on public offering, ending September 30, 2026, with $1.31 billion in total assets including $745.3 million in cash and marketable securities.

Key figure
Net loss $94.2M
4:33 PM ET Form 4
Insider Selling Teladoc Health, Inc. TDOC

Teladoc Health President, International Carlos Nueno Sells $271K of Stock

Carlos Nueno, President, International, sold 29,432 shares of Teladoc Health, Inc. at $9.20 a share, worth $271K in total on Nov 6, 2026. Shares held after the trade: 35,312 (-45.5%).

Value
$271K
Shares
29,432
Price
$9.20
Role
President, International
Holding change
-45.5%
Trade date
Nov 6, 2026
4:33 PM ET 10-Q
Financial Results Select Water Solutions, Inc. WTTR

Select Water Solutions Q3 2026 Results: Net Income $20.6M, Up 668.1% YoY

Select Water Solutions reported a significant increase in total revenue to $412.2 million for the third quarter of 2026, up from $322.2 million in the prior year. Net income attributable to the company rose to $20.6 million ($0.16 per diluted Class A share) compared to $2.7 million in the same period of 2025, driven by strong performance in the Water Infrastructure and Water Services segments.

Key figure
Net income $20.6M · +668.1% YoY
4:33 PM ET 10-Q
Financial Results James River Group Holdings, Inc. JRVR

James River Group Holdings Q3 2026 Results: Net Loss of $187M

James River Group Holdings, Inc. reported a decrease in total invested assets to $1.68 billion as of September 30, 2026, compared to $1.70 billion at year-end 2025. The company completed a domestication from Bermuda to Delaware in late 2025 and is currently classified as an accelerated filer with 46,249,038 shares of common stock outstanding.

Key figure
Net loss $187M
4:33 PM ET 10-Q
Financial Results Take Two Interactive Software Inc TTWO ▶ Call

Take Two Interactive Software Q2 2026 Results: Net Loss of $54M, Loss Narrows

Take-Two Interactive reported a net loss of $54.0 million for the quarter ended September 30, 2026, an improvement from a $133.9 million loss in the prior year. Total net revenue decreased to $1.50 billion from $1.77 billion, while the company maintained a strong liquidity position with $1.15 billion in cash and cash equivalents.

Key figure
Net loss $54M
4:33 PM ET Form 4
Insider Buying Six Flags Entertainment Corporation FUN

Six Flags Entertainment CLO Christopher Lawrence Bennett Buys $46.6K of Stock

Christopher Lawrence Bennett, CLO, bought 5,000 shares of Six Flags Entertainment Corporation at $9.32 a share, worth $46.6K in total on Nov 6, 2026. Shares held after the trade: 51,697 (+10.7%).

Value
$46.6K
Shares
5,000
Price
$9.32
Role
CLO
Holding change
+10.7%
Trade date
Nov 6, 2026
4:32 PM ET 8-K
Leadership Change GeoVax Labs, Inc. GOVX

GeoVax Labs Leadership Change

GeoVax Labs appointed Shahin Behroyan to its Board of Directors and named Tyler O’Brien as interim Chief Executive Officer and Chairman of the Board. Mr. Behroyan fills a vacancy following the resignation of five former directors, while Mr. O'Brien will serve as the principal executive officer until a permanent CEO is designated.

4:32 PM ET 10-Q
Financial Results Orasure Technologies Inc OSUR

Orasure Technologies Q3 2026 Results: Net Loss of $13.1M, Loss Narrows

OraSure Technologies reported a net loss of $13.1 million for Q3 2026, a slight improvement from the $13.7 million loss in the prior year period, despite a 14% increase in total net revenues to $30.9 million. For the first nine months of 2026, the company significantly reduced its operating loss to $30.8 million, aided by a $22.5 million gain from the change in fair value of acquisition-related contingent consideration.

Key figure
Net loss $13.1M
4:32 PM ET 10-Q
Financial Results Ispire Technology Inc. ISPR

Ispire Technology Q1 2026 Results: Net Loss of $6.44M, Loss Widens

For the quarter ended September 30, 2026, Ispire Technology Inc. reported revenue of $27.54 million, a decrease from $30.35 million in the prior year period. The company experienced a net loss for the quarter, contributing to an accumulated deficit of $87.71 million and a total stockholders' deficit of $34.85 million.

Key figure
Net loss $6.44M
4:32 PM ET 10-Q
Financial Results Abeona Therapeutics Inc. ABEO

Abeona Therapeutics Q3 2026 Results: Net Loss of $4.81M, Loss Narrows

Abeona Therapeutics reported a decrease in cash and short-term investments to $134.9 million as of September 30, 2026, compared to $191.4 million at year-end 2025. The company is focused on the commercialization of ZEVASKYN and the development of ABO-801, while noting a private placement transaction announced on November 9, 2026.

Key figure
Net loss $4.81M
4:32 PM ET 10-Q
Financial Results Zeta Global Holdings Corp. ZETA

Zeta Global Holdings Q3 2026 Results: Turns Profitable, Net Income $38.3M

Zeta Global Holdings Corp. reported its third-quarter 2026 results, noting its status as a large accelerated filer with 255,458,977 total shares outstanding as of November 2, 2026. The filing highlights risks related to long sales cycles, dependence on super-scaled customers, and potential fluctuations in revenue during election years.

Key figure
Net income $38.3M
4:32 PM ET 8-K
Financial Results Viant Technology Inc. DSP

Viant Technology Financial Results

Viant Technology reported Q3 2026 financial results with revenue increasing 29% year-over-year to $110.4 million, driven by a 40% increase in Connected TV (CTV) advertiser spend. Alongside the results, the company announced a $50 million increase to its stock repurchase program and the acquisition of Waymark, a generative AI video creative platform.

Term
Q3 2026

“Viant delivered record third quarter results, exceeding the high-end of our guidance range for contribution ex-TAC and adjusted EBITDA. Our ongoing momentum can be directly attributed to our recent evolution into a comprehensive advertising intelligence company.”

Tim Vanderhook, Co-Founder and CEO

“By combining Waymark's generative AI with our audience, content, and attention intelligence, we can empower advertisers of all sizes to produce audience tailored, contextually relevant, and attention-optimized creatives in minutes and at a fraction of traditional costs.”

Tim Vanderhook, Co-Founder and CEO
4:32 PM ET 8-K
Financial Results Jbs N.V. JBS

Jbs Financial Results

JBS N.V. reported third quarter 2026 net sales of $22.7 billion, a 1% increase year-over-year, though net income fell significantly to $164 million ($0.15 per share). The company faced a challenging operating environment that saw Adjusted EBITDA drop 36% to $1.18 billion and leverage increase to 3.54x. Management noted that while JBS Brazil was impacted by lower China exports, the North American beef segment returned to profitability by the end of the quarter.

Term
Q3 2026

“In 3Q26, JBS faced a more challenging operating environment across several of its business units. The weaker operating performance resulted in an increase in leverage to 3.54x. JBS Beef North America returned to positive adjusted EBITDA under US GAAP, supported by better market conditions and continued improvements in operational integration, commercial execution and industrial efficiency.”

Gilberto Tomazoni — Global CEO
4:32 PM ET 8-K/A
Financial Results Tecnoglass Holdings Inc. TGLS

Tecnoglass Holdings Financial Results

Tecnoglass Holdings Inc. filed an amendment to its Q3 2026 earnings report to correct the accounting for deferred income taxes related to treasury stock fair value changes. The non-cash correction increased the income tax provision by $6.0 million, resulting in a decrease in net income from $22.8 million to $16.7 million for the quarter. The adjustment had no impact on the company's reported revenue, operating income, or Adjusted EBITDA.

Term
Q3 2026
4:32 PM ET Form 4
Insider Buying Orchestra BioMed Holdings, Inc. OBIO

Orchestra BioMed Holdings Insider Eric S. Fain Buys $100K of Stock

Eric S. Fain bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 119,630 (+20.1%).

Value
$100K
Shares
20,000
Price
$5.00
Holding change
+20.1%
Trade date
Nov 9, 2026
4:32 PM ET Form 4
Insider Selling Analog Devices Inc ADI

Analog Devices Insider Ray Stata Sells $493K of Stock

Ray Stata sold 1,309 shares of Analog Devices Inc at $361.83 to $394.53 a share (average $376.53) in 18 transactions, worth $493K in total on Nov 5, 2026. Shares held after the trade: 104,622 (-0.1%).

Value
$493K
Shares
1,309
Average price
$376.53
Holding change
-0.1%
Trade date
Nov 5, 2026
4:32 PM ET Form 4
Insider Buying Orchestra BioMed Holdings, Inc. OBIO

Orchestra BioMed Holdings Insider David Pacitti Buys $100K of Stock

David Pacitti bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 74,750 (+36.5%).

Value
$100K
Shares
20,000
Price
$5.00
Holding change
+36.5%
Trade date
Nov 9, 2026
4:32 PM ET 10-Q
Financial Results Tecnoglass Holdings Inc. TGLS

Tecnoglass Holdings Q3 2026 Results: Net Income $16.7M, Down 64.6% YoY

Tecnoglass Holdings Inc. reported total operating revenues of $854.9 million for the nine months ended September 30, 2026, compared to $738.3 million in the prior year period. Net income for the first nine months of 2026 was $73.2 million, a decrease from $133.5 million in 2025, primarily driven by higher cost of sales and operating expenses.

Key figure
Net income $16.7M · -64.6% YoY
4:32 PM ET 8-K
Investor Presentation Rafael Holdings, Inc. RFL

Rafael Holdings Investor Presentation

Rafael Holdings filed a formal investor presentation deck (Exhibit 99.1) following its October 2026 NDA submission for remibetadex. The presentation highlights topline Phase 3 data in Niemann-Pick Disease Type C (NPC), including a prespecified analysis showing a 71% relative slowing of disease progression in a specific patient subgroup.

4:32 PM ET 10-Q
Financial Results Hinge Health, Inc. HNGE

Hinge Health Q3 2026 Results: Turns Profitable, Net Income $57.4M

Hinge Health, Inc. filed its Form 10-Q for the quarter ended September 30, 2026, reporting a dual-class common stock structure with 68,485,043 Class A and 12,786,259 Class B shares outstanding. The company highlights its expansion into Migraine and Gastrointestinal care programs and the acquisition of Cylinder Health, Inc., while cautioning that it has a history of net losses and may not achieve profitability.

Key figure
Net income $57.4M
4:32 PM ET 8-K
Investor Presentation Armstrong World Industries Inc AWI

Armstrong World Industries Investor Presentation

Armstrong World Industries announced that its CEO Mark Hershey and CFO Chris Calzaretta will host investor meetings at the Baird Global Industrial Conference on November 10-11, 2026. In connection with the event, the company filed an updated investor presentation as an exhibit to its 8-K filing.

4:32 PM ET Form 4
Insider Selling Trex Co Inc TREX

Trex Co SVP, CLO and Secretary Amy M. Fernandez Sells $71.2K of Stock

Amy M. Fernandez, SVP, CLO and Secretary, sold 1,231 shares of Trex Co Inc at $57.87 a share, worth $71.2K in total on Nov 5, 2026. Shares held after the trade: 66,563 (-1.8%).

Value
$71.2K
Shares
1,231
Price
$57.87
Role
SVP, CLO and Secretary
Holding change
-1.8%
Trade date
Nov 5, 2026
4:32 PM ET Form 4
Insider Buying Orchestra BioMed Holdings, Inc. OBIO

Orchestra BioMed Holdings Insider David P. Hochman Buys $25K of Stock

David P. Hochman bought 5,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $25K in total on Nov 9, 2026. Shares held after the trade: 437,916 (+1.2%).

Value
$25K
Shares
5,000
Price
$5.00
Holding change
+1.2%
Trade date
Nov 9, 2026
4:32 PM ET 8-K
Divestiture Kbr, Inc. KBR

Kbr Divestiture

KBR provided a status update on the planned tax-free spin-off of its Mission Technology Solutions business into an independent public company named Trinzic, Inc., targeted for completion on January 4, 2027. In connection with the separation, KBR announced the retirement of board members Wendy Masiello and Nchacha Etta, who will join the Trinzic board, and the retirement of EVP Mark W. Sopp.

4:32 PM ET 8-K
Loan & Debt Apple Inc. AAPL

Apple $7.5B Debt Financing with Goldman Sachs & Co. LLC

Apple Inc. completed the issuance and sale of $7.5 billion in aggregate principal amount of senior unsecured notes across seven different tranches. The offering includes both floating rate and fixed rate notes with maturities ranging from 2028 to 2036, intended for general corporate purposes.

Value
$7.5B
Counterparty
Goldman Sachs & Co. LLC, BofA Securities, Inc., Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC
Term
through Nov 2036
4:31 PM ET 8-K
Leadership Change Vestis Corp VSTS

Vestis Leadership Change

John Laveck notified Vestis Corporation of his intention to resign as Vice President and Chief Accounting Officer, effective December 11, 2026. CFO Russell T. Tiejema will assume the role of principal accounting officer on an interim basis until a successor is appointed.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.